|
WO2006074373A2
|
|
Immunochemically modified and sterilized xenografts and allografts
|
|
US7064187B2
|
|
Substantially non-immunogenic injectable collagen
|
|
EP1545401A1
|
|
Galactosidase-treated prosthetic devices
|
|
WO03097809A2
|
|
Sterilized xenograft tissue
|
|
WO02089711A1
|
|
Submucosal xenografts
|
|
CA2441888A1
|
|
Xenograft bone matrix for orthopedic applications
|
|
US6383732B1
|
|
Method of preparing xenograft heart valves
|
|
US6972041B1
|
|
Bone xenografts
|
|
WO9951170A1
|
|
Bone xenografts
|
|
EP1061866A1
|
|
Bone xenografts
|
|
AU3005399A
|
|
Bone xenografts
|
|
US6231608B1
|
|
Aldehyde and glycosidase-treated soft and bone tissue xenografts
|
|
US6267786B1
|
|
Proteoglycan-reduced soft tissue xenografts
|
|
CA2349562A1
|
|
Soft tissue xenografts
|
|
US5944755A
|
|
Articular cartilage xenografts
|
|
US6110206A
|
|
Anterior cruciate ligament xenografts
|
|
US5984858A
|
|
Meniscal xenografts
|
|
US5922027A
|
|
Articular cartilage heterografts
|
|
US5913900A
|
|
Substantially native meniscal cartilage heterografts
|
|
US5902338A
|
|
Anterior cruciate ligament heterograft
|
